nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Sulfonamides—Acetazolamide—epilepsy syndrome	0.313	0.569	CiPCiCtD
Sulfamethoxazole—Sulfonamides—Zonisamide—epilepsy syndrome	0.238	0.431	CiPCiCtD
Sulfamethoxazole—NAT2—Clonazepam—epilepsy syndrome	0.0884	0.308	CbGbCtD
Sulfamethoxazole—ALB—epilepsy syndrome	0.0491	1	CbGaD
Sulfamethoxazole—UGT1A9—Propofol—epilepsy syndrome	0.0171	0.0597	CbGbCtD
Sulfamethoxazole—UGT1A9—Valproic Acid—epilepsy syndrome	0.0122	0.0426	CbGbCtD
Sulfamethoxazole—ALB—Oxcarbazepine—epilepsy syndrome	0.0101	0.0352	CbGbCtD
Sulfamethoxazole—ALB—Fosphenytoin—epilepsy syndrome	0.00884	0.0308	CbGbCtD
Sulfamethoxazole—ALB—Clonazepam—epilepsy syndrome	0.008	0.0278	CbGbCtD
Sulfamethoxazole—CYP2C8—Trimethadione—epilepsy syndrome	0.00727	0.0253	CbGbCtD
Sulfamethoxazole—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00683	0.0238	CbGbCtD
Sulfamethoxazole—ALB—Rufinamide—epilepsy syndrome	0.00652	0.0227	CbGbCtD
Sulfamethoxazole—PTGS1—Diazepam—epilepsy syndrome	0.00645	0.0224	CbGbCtD
Sulfamethoxazole—ALB—Phenytoin—epilepsy syndrome	0.0057	0.0198	CbGbCtD
Sulfamethoxazole—ALB—Propofol—epilepsy syndrome	0.00531	0.0185	CbGbCtD
Sulfamethoxazole—PTGS1—Valproic Acid—epilepsy syndrome	0.00508	0.0177	CbGbCtD
Sulfamethoxazole—CYP2C9—Trimethadione—epilepsy syndrome	0.00507	0.0177	CbGbCtD
Sulfamethoxazole—CYP2C8—Carbamazepine—epilepsy syndrome	0.00491	0.0171	CbGbCtD
Sulfamethoxazole—ALB—Diazepam—epilepsy syndrome	0.00481	0.0168	CbGbCtD
Sulfamethoxazole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00477	0.0166	CbGbCtD
Sulfamethoxazole—CYP2C8—Primidone—epilepsy syndrome	0.00458	0.016	CbGbCtD
Sulfamethoxazole—CYP2C8—Phenytoin—epilepsy syndrome	0.0044	0.0153	CbGbCtD
Sulfamethoxazole—CYP2C8—Propofol—epilepsy syndrome	0.00411	0.0143	CbGbCtD
Sulfamethoxazole—CYP2C8—Phenobarbital—epilepsy syndrome	0.00392	0.0137	CbGbCtD
Sulfamethoxazole—CYP2C8—Diazepam—epilepsy syndrome	0.00372	0.013	CbGbCtD
Sulfamethoxazole—CYP2C9—Carbamazepine—epilepsy syndrome	0.00342	0.0119	CbGbCtD
Sulfamethoxazole—CYP2C9—Primidone—epilepsy syndrome	0.0032	0.0111	CbGbCtD
Sulfamethoxazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00317	0.011	CbGbCtD
Sulfamethoxazole—CYP2C9—Phenytoin—epilepsy syndrome	0.00307	0.0107	CbGbCtD
Sulfamethoxazole—CYP3A4—Trimethadione—epilepsy syndrome	0.00295	0.0103	CbGbCtD
Sulfamethoxazole—CYP3A4—Felbamate—epilepsy syndrome	0.00295	0.0103	CbGbCtD
Sulfamethoxazole—CYP2C8—Valproic Acid—epilepsy syndrome	0.00293	0.0102	CbGbCtD
Sulfamethoxazole—CYP2C9—Propofol—epilepsy syndrome	0.00286	0.00997	CbGbCtD
Sulfamethoxazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00277	0.00965	CbGbCtD
Sulfamethoxazole—CYP2C9—Phenobarbital—epilepsy syndrome	0.00274	0.00953	CbGbCtD
Sulfamethoxazole—CYP2C9—Diazepam—epilepsy syndrome	0.00259	0.00904	CbGbCtD
Sulfamethoxazole—CYP3A4—Clonazepam—epilepsy syndrome	0.00251	0.00873	CbGbCtD
Sulfamethoxazole—CYP3A4—Clobazam—epilepsy syndrome	0.0024	0.00837	CbGbCtD
Sulfamethoxazole—CYP2C9—Valproic Acid—epilepsy syndrome	0.00205	0.00712	CbGbCtD
Sulfamethoxazole—CYP3A4—Rufinamide—epilepsy syndrome	0.00204	0.00711	CbGbCtD
Sulfamethoxazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00199	0.00693	CbGbCtD
Sulfamethoxazole—CYP3A4—Primidone—epilepsy syndrome	0.00186	0.00647	CbGbCtD
Sulfamethoxazole—CYP3A4—Phenytoin—epilepsy syndrome	0.00179	0.00622	CbGbCtD
Sulfamethoxazole—CYP3A4—Propofol—epilepsy syndrome	0.00167	0.0058	CbGbCtD
Sulfamethoxazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00159	0.00554	CbGbCtD
Sulfamethoxazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00159	0.00554	CbGbCtD
Sulfamethoxazole—CYP3A4—Midazolam—epilepsy syndrome	0.00157	0.00546	CbGbCtD
Sulfamethoxazole—CYP3A4—Diazepam—epilepsy syndrome	0.00151	0.00525	CbGbCtD
Sulfamethoxazole—CYP3A4—Zonisamide—epilepsy syndrome	0.00147	0.00513	CbGbCtD
Sulfamethoxazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00119	0.00414	CbGbCtD
Sulfamethoxazole—CYP3A4—Topiramate—epilepsy syndrome	0.00107	0.00374	CbGbCtD
Sulfamethoxazole—Glisoxepide—KCNJ11—epilepsy syndrome	0.000348	0.418	CrCbGaD
Sulfamethoxazole—Sulfamethazine—ALB—epilepsy syndrome	8.74e-05	0.105	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—epilepsy syndrome	8.54e-05	0.102	CrCbGaD
Sulfamethoxazole—Sulfamethizole—ALB—epilepsy syndrome	6.62e-05	0.0794	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2C19—epilepsy syndrome	5.87e-05	0.0705	CrCbGaD
Sulfamethoxazole—Sulfaphenazole—CYP2D6—epilepsy syndrome	5.87e-05	0.0704	CrCbGaD
Sulfamethoxazole—Dapsone—CYP2C19—epilepsy syndrome	5.24e-05	0.0629	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2D6—epilepsy syndrome	4.36e-05	0.0523	CrCbGaD
Sulfamethoxazole—Dapsone—PTGS2—epilepsy syndrome	3.26e-05	0.0392	CrCbGaD
Sulfamethoxazole—Myalgia—Valproic Acid—epilepsy syndrome	3.15e-05	0.000356	CcSEcCtD
Sulfamethoxazole—Rash—Midazolam—epilepsy syndrome	3.13e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Dizziness—Fosphenytoin—epilepsy syndrome	3.13e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	3.13e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Dermatitis—Midazolam—epilepsy syndrome	3.13e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Urticaria—Carbamazepine—epilepsy syndrome	3.13e-05	0.000353	CcSEcCtD
Sulfamethoxazole—Vomiting—Levetiracetam—epilepsy syndrome	3.12e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Headache—Midazolam—epilepsy syndrome	3.11e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Pruritus—Felbamate—epilepsy syndrome	3.11e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Carbamazepine—epilepsy syndrome	3.11e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Carbamazepine—epilepsy syndrome	3.11e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Diazepam—epilepsy syndrome	3.11e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	3.11e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Rash—Levetiracetam—epilepsy syndrome	3.09e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Dermatitis—Levetiracetam—epilepsy syndrome	3.09e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Asthenia—Zonisamide—epilepsy syndrome	3.09e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Mental disorder—Gabapentin—epilepsy syndrome	3.09e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Topiramate—epilepsy syndrome	3.08e-05	0.000348	CcSEcCtD
Sulfamethoxazole—Headache—Levetiracetam—epilepsy syndrome	3.07e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Malnutrition—Gabapentin—epilepsy syndrome	3.07e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Angioedema—Pregabalin—epilepsy syndrome	3.06e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Clonazepam—epilepsy syndrome	3.06e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Dizziness—Vigabatrin—epilepsy syndrome	3.05e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Pruritus—Zonisamide—epilepsy syndrome	3.05e-05	0.000344	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Phenytoin—epilepsy syndrome	3.04e-05	0.000343	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.02e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Urticaria—Lamotrigine—epilepsy syndrome	3.02e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.02e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Nausea—Propofol—epilepsy syndrome	3.02e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Tension—Gabapentin—epilepsy syndrome	3.01e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Vomiting—Fosphenytoin—epilepsy syndrome	3.01e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Felbamate—epilepsy syndrome	3.01e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Vertigo—Pregabalin—epilepsy syndrome	3.01e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Lamotrigine—epilepsy syndrome	3.01e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Lamotrigine—epilepsy syndrome	3.01e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Dizziness—Diazepam—epilepsy syndrome	3.01e-05	0.000339	CcSEcCtD
Sulfamethoxazole—Leukopenia—Pregabalin—epilepsy syndrome	3e-05	0.000338	CcSEcCtD
Sulfamethoxazole—Rash—Fosphenytoin—epilepsy syndrome	2.99e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fosphenytoin—epilepsy syndrome	2.98e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Nervousness—Gabapentin—epilepsy syndrome	2.98e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Asthenia—Clonazepam—epilepsy syndrome	2.98e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Headache—Fosphenytoin—epilepsy syndrome	2.97e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Hepatitis—Topiramate—epilepsy syndrome	2.97e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.96e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.96e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Asthenia—Phenytoin—epilepsy syndrome	2.96e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Nausea—Midazolam—epilepsy syndrome	2.95e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Hallucination—Topiramate—epilepsy syndrome	2.95e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Zonisamide—epilepsy syndrome	2.95e-05	0.000333	CcSEcCtD
Sulfamethoxazole—Asthenia—Oxcarbazepine—epilepsy syndrome	2.94e-05	0.000332	CcSEcCtD
Sulfamethoxazole—Pruritus—Clonazepam—epilepsy syndrome	2.94e-05	0.000332	CcSEcCtD
Sulfamethoxazole—Vomiting—Vigabatrin—epilepsy syndrome	2.94e-05	0.000332	CcSEcCtD
Sulfamethoxazole—Skin disorder—Valproic Acid—epilepsy syndrome	2.94e-05	0.000332	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Topiramate—epilepsy syndrome	2.93e-05	0.000331	CcSEcCtD
Sulfamethoxazole—Cough—Pregabalin—epilepsy syndrome	2.92e-05	0.00033	CcSEcCtD
Sulfamethoxazole—Pruritus—Phenytoin—epilepsy syndrome	2.92e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Topiramate—epilepsy syndrome	2.92e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Nausea—Levetiracetam—epilepsy syndrome	2.92e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Rash—Vigabatrin—epilepsy syndrome	2.91e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Dizziness—Felbamate—epilepsy syndrome	2.91e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vigabatrin—epilepsy syndrome	2.91e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Topiramate—epilepsy syndrome	2.91e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Pruritus—Oxcarbazepine—epilepsy syndrome	2.9e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Convulsion—Pregabalin—epilepsy syndrome	2.9e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.9e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Headache—Vigabatrin—epilepsy syndrome	2.89e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Vomiting—Diazepam—epilepsy syndrome	2.89e-05	0.000326	CcSEcCtD
Sulfamethoxazole—Anorexia—Valproic Acid—epilepsy syndrome	2.88e-05	0.000325	CcSEcCtD
Sulfamethoxazole—Rash—Diazepam—epilepsy syndrome	2.87e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Dermatitis—Diazepam—epilepsy syndrome	2.86e-05	0.000323	CcSEcCtD
Sulfamethoxazole—Myalgia—Pregabalin—epilepsy syndrome	2.85e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Arthralgia—Pregabalin—epilepsy syndrome	2.85e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Dizziness—Zonisamide—epilepsy syndrome	2.85e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Headache—Diazepam—epilepsy syndrome	2.85e-05	0.000322	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Clonazepam—epilepsy syndrome	2.84e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.83e-05	0.00032	CcSEcCtD
Sulfamethoxazole—Asthenia—Carbamazepine—epilepsy syndrome	2.82e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Phenytoin—epilepsy syndrome	2.82e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Nausea—Fosphenytoin—epilepsy syndrome	2.81e-05	0.000318	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.81e-05	0.000317	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Topiramate—epilepsy syndrome	2.81e-05	0.000317	CcSEcCtD
Sulfamethoxazole—Angioedema—Gabapentin—epilepsy syndrome	2.81e-05	0.000317	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.8e-05	0.000316	CcSEcCtD
Sulfamethoxazole—Vomiting—Felbamate—epilepsy syndrome	2.8e-05	0.000316	CcSEcCtD
Sulfamethoxazole—Pruritus—Carbamazepine—epilepsy syndrome	2.78e-05	0.000314	CcSEcCtD
Sulfamethoxazole—Rash—Felbamate—epilepsy syndrome	2.77e-05	0.000313	CcSEcCtD
Sulfamethoxazole—Eye disorder—Topiramate—epilepsy syndrome	2.77e-05	0.000313	CcSEcCtD
Sulfamethoxazole—Dermatitis—Felbamate—epilepsy syndrome	2.77e-05	0.000313	CcSEcCtD
Sulfamethoxazole—Tinnitus—Topiramate—epilepsy syndrome	2.77e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Vertigo—Gabapentin—epilepsy syndrome	2.76e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Headache—Felbamate—epilepsy syndrome	2.76e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.75e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Leukopenia—Gabapentin—epilepsy syndrome	2.75e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Dizziness—Clonazepam—epilepsy syndrome	2.74e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Nausea—Vigabatrin—epilepsy syndrome	2.74e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Vomiting—Zonisamide—epilepsy syndrome	2.74e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Insomnia—Valproic Acid—epilepsy syndrome	2.73e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.73e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Asthenia—Lamotrigine—epilepsy syndrome	2.73e-05	0.000308	CcSEcCtD
Sulfamethoxazole—Dizziness—Phenytoin—epilepsy syndrome	2.73e-05	0.000308	CcSEcCtD
Sulfamethoxazole—Rash—Zonisamide—epilepsy syndrome	2.72e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Dermatitis—Zonisamide—epilepsy syndrome	2.71e-05	0.000306	CcSEcCtD
Sulfamethoxazole—Dizziness—Oxcarbazepine—epilepsy syndrome	2.71e-05	0.000306	CcSEcCtD
Sulfamethoxazole—Nausea—Diazepam—epilepsy syndrome	2.7e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Headache—Zonisamide—epilepsy syndrome	2.7e-05	0.000305	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Valproic Acid—epilepsy syndrome	2.69e-05	0.000304	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Carbamazepine—epilepsy syndrome	2.69e-05	0.000304	CcSEcCtD
Sulfamethoxazole—Pruritus—Lamotrigine—epilepsy syndrome	2.69e-05	0.000304	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Topiramate—epilepsy syndrome	2.68e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Pregabalin—epilepsy syndrome	2.68e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Cough—Gabapentin—epilepsy syndrome	2.68e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.68e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Topiramate—epilepsy syndrome	2.67e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Chills—Topiramate—epilepsy syndrome	2.66e-05	0.000301	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Valproic Acid—epilepsy syndrome	2.66e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Convulsion—Gabapentin—epilepsy syndrome	2.66e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Skin disorder—Pregabalin—epilepsy syndrome	2.65e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Vomiting—Clonazepam—epilepsy syndrome	2.64e-05	0.000298	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Valproic Acid—epilepsy syndrome	2.63e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Vomiting—Phenytoin—epilepsy syndrome	2.62e-05	0.000296	CcSEcCtD
Sulfamethoxazole—Rash—Clonazepam—epilepsy syndrome	2.62e-05	0.000296	CcSEcCtD
Sulfamethoxazole—Dermatitis—Clonazepam—epilepsy syndrome	2.61e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Myalgia—Gabapentin—epilepsy syndrome	2.61e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Arthralgia—Gabapentin—epilepsy syndrome	2.61e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Nausea—Felbamate—epilepsy syndrome	2.61e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.61e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Vomiting—Oxcarbazepine—epilepsy syndrome	2.61e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Fatigue—Valproic Acid—epilepsy syndrome	2.61e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Anorexia—Pregabalin—epilepsy syndrome	2.6e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Dizziness—Carbamazepine—epilepsy syndrome	2.6e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Lamotrigine—epilepsy syndrome	2.6e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Headache—Clonazepam—epilepsy syndrome	2.6e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Rash—Phenytoin—epilepsy syndrome	2.6e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Mental disorder—Topiramate—epilepsy syndrome	2.6e-05	0.000294	CcSEcCtD
Sulfamethoxazole—Dermatitis—Phenytoin—epilepsy syndrome	2.6e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.6e-05	0.000293	CcSEcCtD
Sulfamethoxazole—Rash—Oxcarbazepine—epilepsy syndrome	2.59e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Headache—Phenytoin—epilepsy syndrome	2.58e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Malnutrition—Topiramate—epilepsy syndrome	2.58e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Headache—Oxcarbazepine—epilepsy syndrome	2.57e-05	0.00029	CcSEcCtD
Sulfamethoxazole—Nausea—Zonisamide—epilepsy syndrome	2.56e-05	0.000289	CcSEcCtD
Sulfamethoxazole—Tension—Topiramate—epilepsy syndrome	2.53e-05	0.000286	CcSEcCtD
Sulfamethoxazole—Dizziness—Lamotrigine—epilepsy syndrome	2.52e-05	0.000284	CcSEcCtD
Sulfamethoxazole—Nervousness—Topiramate—epilepsy syndrome	2.51e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.51e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Vomiting—Carbamazepine—epilepsy syndrome	2.5e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.49e-05	0.000281	CcSEcCtD
Sulfamethoxazole—Rash—Carbamazepine—epilepsy syndrome	2.48e-05	0.00028	CcSEcCtD
Sulfamethoxazole—Dermatitis—Carbamazepine—epilepsy syndrome	2.48e-05	0.00028	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.47e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Insomnia—Pregabalin—epilepsy syndrome	2.47e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Nausea—Clonazepam—epilepsy syndrome	2.47e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Headache—Carbamazepine—epilepsy syndrome	2.47e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Gabapentin—epilepsy syndrome	2.46e-05	0.000277	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.45e-05	0.000277	CcSEcCtD
Sulfamethoxazole—Nausea—Phenytoin—epilepsy syndrome	2.45e-05	0.000277	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Pregabalin—epilepsy syndrome	2.44e-05	0.000275	CcSEcCtD
Sulfamethoxazole—Nausea—Oxcarbazepine—epilepsy syndrome	2.44e-05	0.000275	CcSEcCtD
Sulfamethoxazole—Skin disorder—Gabapentin—epilepsy syndrome	2.43e-05	0.000275	CcSEcCtD
Sulfamethoxazole—Vomiting—Lamotrigine—epilepsy syndrome	2.42e-05	0.000273	CcSEcCtD
Sulfamethoxazole—Urticaria—Valproic Acid—epilepsy syndrome	2.4e-05	0.000271	CcSEcCtD
Sulfamethoxazole—Rash—Lamotrigine—epilepsy syndrome	2.4e-05	0.000271	CcSEcCtD
Sulfamethoxazole—Dermatitis—Lamotrigine—epilepsy syndrome	2.4e-05	0.000271	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Valproic Acid—epilepsy syndrome	2.39e-05	0.00027	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Valproic Acid—epilepsy syndrome	2.39e-05	0.00027	CcSEcCtD
Sulfamethoxazole—Anorexia—Gabapentin—epilepsy syndrome	2.39e-05	0.00027	CcSEcCtD
Sulfamethoxazole—Headache—Lamotrigine—epilepsy syndrome	2.38e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Pregabalin—epilepsy syndrome	2.38e-05	0.000268	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.36e-05	0.000266	CcSEcCtD
Sulfamethoxazole—Fatigue—Pregabalin—epilepsy syndrome	2.36e-05	0.000266	CcSEcCtD
Sulfamethoxazole—Nausea—Carbamazepine—epilepsy syndrome	2.34e-05	0.000264	CcSEcCtD
Sulfamethoxazole—Vertigo—Topiramate—epilepsy syndrome	2.32e-05	0.000262	CcSEcCtD
Sulfamethoxazole—Leukopenia—Topiramate—epilepsy syndrome	2.31e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.28e-05	0.000258	CcSEcCtD
Sulfamethoxazole—Insomnia—Gabapentin—epilepsy syndrome	2.27e-05	0.000256	CcSEcCtD
Sulfamethoxazole—Nausea—Lamotrigine—epilepsy syndrome	2.26e-05	0.000255	CcSEcCtD
Sulfamethoxazole—Cough—Topiramate—epilepsy syndrome	2.25e-05	0.000255	CcSEcCtD
Sulfamethoxazole—Convulsion—Topiramate—epilepsy syndrome	2.24e-05	0.000253	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.23e-05	0.000252	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Gabapentin—epilepsy syndrome	2.23e-05	0.000252	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.23e-05	0.000251	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Gabapentin—epilepsy syndrome	2.21e-05	0.000249	CcSEcCtD
Sulfamethoxazole—Myalgia—Topiramate—epilepsy syndrome	2.2e-05	0.000248	CcSEcCtD
Sulfamethoxazole—Arthralgia—Topiramate—epilepsy syndrome	2.2e-05	0.000248	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.18e-05	0.000247	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Gabapentin—epilepsy syndrome	2.18e-05	0.000246	CcSEcCtD
Sulfamethoxazole—Urticaria—Pregabalin—epilepsy syndrome	2.17e-05	0.000245	CcSEcCtD
Sulfamethoxazole—Asthenia—Valproic Acid—epilepsy syndrome	2.17e-05	0.000245	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.16e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Fatigue—Gabapentin—epilepsy syndrome	2.16e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Pregabalin—epilepsy syndrome	2.16e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Pregabalin—epilepsy syndrome	2.16e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Pruritus—Valproic Acid—epilepsy syndrome	2.14e-05	0.000241	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Valproic Acid—epilepsy syndrome	2.07e-05	0.000234	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Topiramate—epilepsy syndrome	2.07e-05	0.000233	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Topiramate—epilepsy syndrome	2.06e-05	0.000233	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.05e-05	0.000231	CcSEcCtD
Sulfamethoxazole—Skin disorder—Topiramate—epilepsy syndrome	2.05e-05	0.000231	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Pregabalin—epilepsy syndrome	2.01e-05	0.000227	CcSEcCtD
Sulfamethoxazole—Anorexia—Topiramate—epilepsy syndrome	2.01e-05	0.000227	CcSEcCtD
Sulfamethoxazole—Dizziness—Valproic Acid—epilepsy syndrome	2e-05	0.000226	CcSEcCtD
Sulfamethoxazole—Urticaria—Gabapentin—epilepsy syndrome	1.99e-05	0.000225	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Gabapentin—epilepsy syndrome	1.98e-05	0.000224	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Gabapentin—epilepsy syndrome	1.98e-05	0.000224	CcSEcCtD
Sulfamethoxazole—Asthenia—Pregabalin—epilepsy syndrome	1.96e-05	0.000221	CcSEcCtD
Sulfamethoxazole—Pruritus—Pregabalin—epilepsy syndrome	1.93e-05	0.000218	CcSEcCtD
Sulfamethoxazole—Vomiting—Valproic Acid—epilepsy syndrome	1.92e-05	0.000217	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.92e-05	0.000217	CcSEcCtD
Sulfamethoxazole—Insomnia—Topiramate—epilepsy syndrome	1.91e-05	0.000215	CcSEcCtD
Sulfamethoxazole—Rash—Valproic Acid—epilepsy syndrome	1.91e-05	0.000215	CcSEcCtD
Sulfamethoxazole—Dermatitis—Valproic Acid—epilepsy syndrome	1.9e-05	0.000215	CcSEcCtD
Sulfamethoxazole—Headache—Valproic Acid—epilepsy syndrome	1.89e-05	0.000214	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Topiramate—epilepsy syndrome	1.88e-05	0.000212	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Pregabalin—epilepsy syndrome	1.87e-05	0.000211	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Topiramate—epilepsy syndrome	1.86e-05	0.00021	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Gabapentin—epilepsy syndrome	1.85e-05	0.000208	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Topiramate—epilepsy syndrome	1.83e-05	0.000207	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.82e-05	0.000206	CcSEcCtD
Sulfamethoxazole—Fatigue—Topiramate—epilepsy syndrome	1.82e-05	0.000205	CcSEcCtD
Sulfamethoxazole—Dizziness—Pregabalin—epilepsy syndrome	1.81e-05	0.000204	CcSEcCtD
Sulfamethoxazole—Asthenia—Gabapentin—epilepsy syndrome	1.8e-05	0.000203	CcSEcCtD
Sulfamethoxazole—Nausea—Valproic Acid—epilepsy syndrome	1.8e-05	0.000203	CcSEcCtD
Sulfamethoxazole—Pruritus—Gabapentin—epilepsy syndrome	1.77e-05	0.0002	CcSEcCtD
Sulfamethoxazole—Vomiting—Pregabalin—epilepsy syndrome	1.74e-05	0.000196	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.72e-05	0.000195	CcSEcCtD
Sulfamethoxazole—Rash—Pregabalin—epilepsy syndrome	1.72e-05	0.000195	CcSEcCtD
Sulfamethoxazole—Dermatitis—Pregabalin—epilepsy syndrome	1.72e-05	0.000194	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Gabapentin—epilepsy syndrome	1.71e-05	0.000194	CcSEcCtD
Sulfamethoxazole—Headache—Pregabalin—epilepsy syndrome	1.71e-05	0.000193	CcSEcCtD
Sulfamethoxazole—Urticaria—Topiramate—epilepsy syndrome	1.67e-05	0.000189	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Topiramate—epilepsy syndrome	1.67e-05	0.000188	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Topiramate—epilepsy syndrome	1.67e-05	0.000188	CcSEcCtD
Sulfamethoxazole—Dizziness—Gabapentin—epilepsy syndrome	1.66e-05	0.000187	CcSEcCtD
Sulfamethoxazole—Nausea—Pregabalin—epilepsy syndrome	1.62e-05	0.000183	CcSEcCtD
Sulfamethoxazole—Vomiting—Gabapentin—epilepsy syndrome	1.59e-05	0.00018	CcSEcCtD
Sulfamethoxazole—Rash—Gabapentin—epilepsy syndrome	1.58e-05	0.000178	CcSEcCtD
Sulfamethoxazole—Dermatitis—Gabapentin—epilepsy syndrome	1.58e-05	0.000178	CcSEcCtD
Sulfamethoxazole—Headache—Gabapentin—epilepsy syndrome	1.57e-05	0.000177	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Topiramate—epilepsy syndrome	1.55e-05	0.000175	CcSEcCtD
Sulfamethoxazole—Asthenia—Topiramate—epilepsy syndrome	1.51e-05	0.000171	CcSEcCtD
Sulfamethoxazole—Pruritus—Topiramate—epilepsy syndrome	1.49e-05	0.000168	CcSEcCtD
Sulfamethoxazole—Nausea—Gabapentin—epilepsy syndrome	1.49e-05	0.000168	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Topiramate—epilepsy syndrome	1.44e-05	0.000163	CcSEcCtD
Sulfamethoxazole—Dizziness—Topiramate—epilepsy syndrome	1.39e-05	0.000157	CcSEcCtD
Sulfamethoxazole—Vomiting—Topiramate—epilepsy syndrome	1.34e-05	0.000151	CcSEcCtD
Sulfamethoxazole—Rash—Topiramate—epilepsy syndrome	1.33e-05	0.00015	CcSEcCtD
Sulfamethoxazole—Dermatitis—Topiramate—epilepsy syndrome	1.33e-05	0.00015	CcSEcCtD
Sulfamethoxazole—Headache—Topiramate—epilepsy syndrome	1.32e-05	0.000149	CcSEcCtD
Sulfamethoxazole—Nausea—Topiramate—epilepsy syndrome	1.25e-05	0.000141	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.54e-06	0.000237	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	5.53e-06	0.000237	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PFKL—epilepsy syndrome	5.53e-06	0.000237	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	5.53e-06	0.000237	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	5.53e-06	0.000237	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	5.53e-06	0.000237	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	5.43e-06	0.000233	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT3—epilepsy syndrome	5.43e-06	0.000233	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	5.4e-06	0.000232	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ASAH1—epilepsy syndrome	5.4e-06	0.000231	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	5.37e-06	0.00023	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.37e-06	0.00023	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLAUR—epilepsy syndrome	5.36e-06	0.00023	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.34e-06	0.000229	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	5.28e-06	0.000226	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.26e-06	0.000225	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—STXBP1—epilepsy syndrome	5.25e-06	0.000225	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NT5E—epilepsy syndrome	5.15e-06	0.000221	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALAD—epilepsy syndrome	5.15e-06	0.000221	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NT5E—epilepsy syndrome	5.12e-06	0.000219	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALAD—epilepsy syndrome	5.12e-06	0.000219	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.09e-06	0.000218	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ATIC—epilepsy syndrome	5.06e-06	0.000217	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—UPB1—epilepsy syndrome	5.06e-06	0.000217	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NEU1—epilepsy syndrome	5.06e-06	0.000217	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.05e-06	0.000217	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP2D6—epilepsy syndrome	5.04e-06	0.000216	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CDC42—epilepsy syndrome	4.95e-06	0.000212	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	4.91e-06	0.00021	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	4.91e-06	0.00021	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALDH7A1—epilepsy syndrome	4.88e-06	0.000209	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CACNA1A—epilepsy syndrome	4.88e-06	0.000209	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	4.87e-06	0.000209	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	4.81e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ADRA2A—epilepsy syndrome	4.8e-06	0.000205	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ST3GAL3—epilepsy syndrome	4.78e-06	0.000205	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—BCHE—epilepsy syndrome	4.78e-06	0.000205	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ADSL—epilepsy syndrome	4.71e-06	0.000202	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GBE1—epilepsy syndrome	4.7e-06	0.000201	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	4.7e-06	0.000201	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCG2—epilepsy syndrome	4.7e-06	0.000201	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ADSL—epilepsy syndrome	4.68e-06	0.000201	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GLUL—epilepsy syndrome	4.62e-06	0.000198	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.6e-06	0.000197	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GLUL—epilepsy syndrome	4.59e-06	0.000197	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	4.58e-06	0.000196	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC2A1—epilepsy syndrome	4.56e-06	0.000195	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	4.55e-06	0.000195	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	4.53e-06	0.000194	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.52e-06	0.000194	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CACNA1D—epilepsy syndrome	4.51e-06	0.000193	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PLCB1—epilepsy syndrome	4.51e-06	0.000193	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TH—epilepsy syndrome	4.49e-06	0.000192	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	4.42e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.42e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—FYN—epilepsy syndrome	4.41e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.4e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.4e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.4e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.4e-06	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.3e-06	0.000184	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	4.24e-06	0.000182	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—YWHAZ—epilepsy syndrome	4.24e-06	0.000182	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TXNRD1—epilepsy syndrome	4.22e-06	0.000181	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NT5E—epilepsy syndrome	4.19e-06	0.00018	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALAD—epilepsy syndrome	4.19e-06	0.00018	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.19e-06	0.00018	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.15e-06	0.000178	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.12e-06	0.000176	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AQP1—epilepsy syndrome	4.12e-06	0.000176	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	4.11e-06	0.000176	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AQP1—epilepsy syndrome	4.09e-06	0.000175	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.09e-06	0.000175	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.09e-06	0.000175	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.08e-06	0.000175	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.02e-06	0.000172	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	4e-06	0.000171	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	4e-06	0.000171	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	3.99e-06	0.000171	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.95e-06	0.000169	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.93e-06	0.000168	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.91e-06	0.000168	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	3.91e-06	0.000168	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—BCHE—epilepsy syndrome	3.89e-06	0.000167	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	3.88e-06	0.000166	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.85e-06	0.000165	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.83e-06	0.000164	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLAU—epilepsy syndrome	3.76e-06	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.76e-06	0.000161	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	3.75e-06	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	3.72e-06	0.00016	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	3.72e-06	0.00016	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	3.71e-06	0.000159	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CHRM3—epilepsy syndrome	3.7e-06	0.000159	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—KCNJ11—epilepsy syndrome	3.7e-06	0.000159	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CAT—epilepsy syndrome	3.7e-06	0.000158	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.69e-06	0.000158	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PLCB1—epilepsy syndrome	3.67e-06	0.000157	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TH—epilepsy syndrome	3.66e-06	0.000157	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.65e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.65e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.65e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.65e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.65e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.6e-06	0.000154	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	3.6e-06	0.000154	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PRKCB—epilepsy syndrome	3.5e-06	0.00015	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.47e-06	0.000149	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS2—epilepsy syndrome	3.46e-06	0.000148	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.45e-06	0.000148	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.45e-06	0.000148	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.4e-06	0.000146	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.38e-06	0.000145	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.35e-06	0.000144	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GPX1—epilepsy syndrome	3.34e-06	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.34e-06	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.34e-06	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.34e-06	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.22e-06	0.000138	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.21e-06	0.000138	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.1e-06	0.000133	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.1e-06	0.000133	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—HMOX1—epilepsy syndrome	3.05e-06	0.000131	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.03e-06	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.03e-06	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.03e-06	0.00013	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCG2—epilepsy syndrome	3.02e-06	0.000129	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAT—epilepsy syndrome	3.01e-06	0.000129	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.96e-06	0.000127	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.94e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.94e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AGT—epilepsy syndrome	2.93e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCB1—epilepsy syndrome	2.93e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.92e-06	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.92e-06	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.92e-06	0.000125	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.9e-06	0.000124	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—epilepsy syndrome	2.87e-06	0.000123	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—epilepsy syndrome	2.84e-06	0.000122	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.84e-06	0.000122	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.82e-06	0.000121	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.76e-06	0.000118	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.76e-06	0.000118	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.76e-06	0.000118	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPX1—epilepsy syndrome	2.73e-06	0.000117	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.66e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.65e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.64e-06	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.64e-06	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.64e-06	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.58e-06	0.000111	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.53e-06	0.000108	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.53e-06	0.000108	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.51e-06	0.000108	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.51e-06	0.000108	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BCHE—epilepsy syndrome	2.5e-06	0.000107	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.48e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.48e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.47e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POMC—epilepsy syndrome	2.47e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.43e-06	0.000104	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.41e-06	0.000103	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.4e-06	0.000103	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.39e-06	0.000103	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AGT—epilepsy syndrome	2.39e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.39e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.37e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.37e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TH—epilepsy syndrome	2.36e-06	0.000101	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLCB1—epilepsy syndrome	2.36e-06	0.000101	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TH—epilepsy syndrome	2.35e-06	0.000101	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—epilepsy syndrome	2.34e-06	0.0001	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.33e-06	9.97e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.31e-06	9.92e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.28e-06	9.75e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—epilepsy syndrome	2.25e-06	9.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.21e-06	9.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.17e-06	9.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.16e-06	9.25e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SRC—epilepsy syndrome	2.06e-06	8.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.06e-06	8.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.05e-06	8.77e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POMC—epilepsy syndrome	2.01e-06	8.62e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—epilepsy syndrome	2e-06	8.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2e-06	8.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2e-06	8.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.97e-06	8.46e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	1.97e-06	8.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMOX1—epilepsy syndrome	1.96e-06	8.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.95e-06	8.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.95e-06	8.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAT—epilepsy syndrome	1.94e-06	8.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.93e-06	8.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TH—epilepsy syndrome	1.92e-06	8.25e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.89e-06	8.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.89e-06	8.12e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—epilepsy syndrome	1.88e-06	8.07e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—epilepsy syndrome	1.83e-06	7.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.76e-06	7.55e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—epilepsy syndrome	1.75e-06	7.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.63e-06	6.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.61e-06	6.88e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—epilepsy syndrome	1.6e-06	6.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.59e-06	6.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.58e-06	6.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.58e-06	6.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.54e-06	6.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.54e-06	6.61e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AGT—epilepsy syndrome	1.54e-06	6.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.51e-06	6.48e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—epilepsy syndrome	1.5e-06	6.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.43e-06	6.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.42e-06	6.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.36e-06	5.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.35e-06	5.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.3e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POMC—epilepsy syndrome	1.29e-06	5.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.29e-06	5.52e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—epilepsy syndrome	1.28e-06	5.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.27e-06	5.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TH—epilepsy syndrome	1.27e-06	5.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.26e-06	5.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.23e-06	5.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.18e-06	5.08e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.06e-06	4.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.06e-06	4.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.05e-06	4.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.04e-06	4.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	4.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.02e-06	4.36e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—epilepsy syndrome	9.89e-07	4.24e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.64e-07	4.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.45e-07	4.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.44e-07	3.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.29e-07	3.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.12e-07	3.48e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—epilepsy syndrome	8.07e-07	3.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.98e-07	2.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.36e-07	2.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.56e-07	2.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.21e-07	2.23e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—epilepsy syndrome	5.18e-07	2.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.24e-07	1.82e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.8e-07	1.2e-05	CbGpPWpGaD
